Contemporary RP-HPLC Strategies for Dual Quantification of Rosuvastatin and Ezetimibe in Combined Dosage Forms: Advances, Challenges, and Future Prospects
International Journal of Pharmacy and Pharmaceutical Research · 2026 · 32 (3) · 64-80
DOI: 10.25166/ijppr.2026.32.3.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy and Pharmaceutical Research, 2026. Verfasst von Abhishek Kumar Srivastava und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Srivastava, A. K., Chauhan, H. S., & Sharma, U. (2026). Contemporary RP-HPLC Strategies for Dual Quantification of Rosuvastatin and Ezetimibe in Combined Dosage Forms: Advances, Challenges, and Future Prospects. International Journal of Pharmacy and Pharmaceutical Research, 32(3), 64-80. https://doi.org/10.25166/ijppr.2026.32.3.8
Vancouver
Srivastava AK, Chauhan HS, Sharma U. Contemporary RP-HPLC Strategies for Dual Quantification of Rosuvastatin and Ezetimibe in Combined Dosage Forms: Advances, Challenges, and Future Prospects. International Journal of Pharmacy and Pharmaceutical Research. 2026;32(3):64-80. doi:10.25166/ijppr.2026.32.3.8
BibTeX
@article{Srivastava2026,
author = {Srivastava, Abhishek Kumar and Chauhan, Hridesh Singh and Sharma, Utkarsh},
title = {Contemporary RP-HPLC Strategies for Dual Quantification of Rosuvastatin and Ezetimibe in Combined Dosage Forms: Advances, Challenges, and Future Prospects},
journal = {International Journal of Pharmacy and Pharmaceutical Research},
year = {2026},
volume = {32},
number = {3},
pages = {64--80},
doi = {10.25166/ijppr.2026.32.3.8}
}
EUVIMED